Dr. Jong Hee Chang, MD, PhD
Claim this profileSeverance Hospital Yonsei University Health System
Clinical Trials Jong Hee Chang, MD, PhD is currently running
More about Jong Hee Chang, MD, PhD
Clinical Trial Related
2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Jong Hee Chang, MD, PhD has experience with
- ONC201
Breakdown of trials Jong Hee Chang, MD, PhD has run
Brain Tumor
Mesial Temporal Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jong Hee Chang, MD, PhD specialize in?
Jong Hee Chang, MD, PhD focuses on Brain Tumor and Mesial Temporal Sclerosis. In particular, much of their work with Brain Tumor has involved H3 K27M positive patients, or patients who are undergoing treatment.
Is Jong Hee Chang, MD, PhD currently recruiting for clinical trials?
Yes, Jong Hee Chang, MD, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Jong Hee Chang, MD, PhD has studied deeply?
Yes, Jong Hee Chang, MD, PhD has studied treatments such as ONC201.
What is the best way to schedule an appointment with Jong Hee Chang, MD, PhD?
Apply for one of the trials that Jong Hee Chang, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.